scholarly article | Q13442814 |
P50 | author | Caroline Genco | Q38319134 |
Frank C Gibson | Q52354500 | ||
P2093 | author name string | C A Genco | |
F C Gibson | |||
P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease | Q30668716 | ||
Animal models for Porphyromonas gingivalis-mediated periodontal disease. | Q31958913 | ||
A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. | Q32036004 | ||
RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model | Q33597234 | ||
Virulence factors of Porphyromonas gingivalis. | Q33752051 | ||
CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice | Q34001072 | ||
Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model | Q34001629 | ||
Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis | Q34004291 | ||
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway | Q34235972 | ||
Periodontal diseases in the United States population | Q34462578 | ||
Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis | Q35495294 | ||
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis | Q35607423 | ||
Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin | Q35778945 | ||
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats | Q36105322 | ||
A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis | Q36962002 | ||
Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. | Q39824101 | ||
Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction | Q40147326 | ||
Bacteriological diagnosis of periodontal disease | Q40981726 | ||
Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion | Q41050913 | ||
Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis | Q44721487 | ||
Characterization of a polysaccharide antigen from Bacteroides gingivalis | Q44822852 | ||
Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases | Q46086294 | ||
Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis | Q47682337 | ||
Involvement of a lysine-specific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis | Q47724105 | ||
Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis | Q47861076 | ||
Host mechanisms in the pathogenesis of periodontal disease | Q47879114 | ||
Genetic variation of Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with arginine or lysine specificity | Q48039254 | ||
Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice | Q72158253 | ||
Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis | Q73427563 | ||
Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis | Q78109544 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunization | Q1415366 |
Porphyromonas gingivalis | Q3214147 | ||
P304 | page(s) | 7959-7963 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1 | |
P478 | volume | 69 |
Q26863436 | Animal models to study host-bacteria interactions involved in periodontitis |
Q35755292 | Antigens of bacteria associated with periodontitis. |
Q40342996 | Apple- and hop-polyphenols protect periodontal ligament cells stimulated with enamel matrix derivative from Porphyromonas gingivalis |
Q57920057 | Arg-gingipain A DNA Vaccine Prevents Alveolar Bone Loss in Mice |
Q38478196 | Cloning and characterization of heavy and light chain genes encoding the FimA-specific monoclonal antibodies that inhibit Porphyromonas gingivalis adhesion |
Q35202486 | Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology |
Q34076596 | Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. |
Q39612929 | Effects of Bio-Oss® and Cerasorb® dental M on the expression of bone-remodeling mediators in human monocytes |
Q37619440 | Emerging roles of immunostimulatory oral bacteria in periodontitis development |
Q81661561 | Evaluation of a monovalent companion animal periodontal disease vaccine in an experimental mouse periodontitis model |
Q37682903 | Feasibility and therapeutic strategies of vaccines against Porphyromonas gingivalis |
Q35066214 | HGP44 induces protection against Porphyromonas gingivalis-Induced alveolar bone loss in mice. |
Q36362686 | Host responses in maintaining periodontal health and determining periodontal disease |
Q45733195 | IgG sera levels against a subset of periodontopathogens and severity of disease in aggressive periodontitis patients: a cross-sectional study of selected pocket sites |
Q37075456 | Immune response and alveolar bone resorption in a mouse model of Treponema denticola infection |
Q36243392 | Immune responses and vaccination against periodontal infections |
Q46651677 | Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production |
Q24554447 | Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model |
Q39654838 | Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model |
Q51142622 | Immunoglobulin G subclass antibody profiles in Porphyromonas gingivalis-associated aggressive and chronic periodontitis patients. |
Q39653247 | Immunologic environment influences macrophage response to Porphyromonas gingivalis. |
Q47852413 | Immunoprotective effects of a hemin-binding peptide derived from hemagglutinin-2 against infection with Porphyromonas gingivalis |
Q46935401 | Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis |
Q44761522 | Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis |
Q35961113 | Methods of detection of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythensis in periodontal microbiology, with special emphasis on advanced molecular techniques: a review |
Q28590692 | Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis |
Q35552587 | Molecular Genetic Analysis of the Virulence of Oral Bacterial Pathogens: An Historical Perspective |
Q38401993 | Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model. |
Q34334149 | Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. |
Q41862930 | Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. |
Q34484762 | Porphyromonas gingivalis Virulence in a Drosophila melanogaster Model |
Q34671776 | Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice |
Q36826931 | Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand |
Q34484633 | Porphyromonas gingivalis-Host Interactions in aDrosophila melanogasterModel |
Q40705302 | Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model. |
Q34674481 | Prevalence of Porphyromonas gingivalis four rag locus genotypes in patients of orthodontic gingivitis and periodontitis |
Q37767239 | Prophylactic vaccination against periodontal disease: a systematic review of preclinical studies |
Q36404753 | Protective and destructive immunity in the periodontium: Part 2--T-cell-mediated immunity in the periodontium |
Q34230397 | Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. |
Q50516275 | Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. |
Q34862986 | Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection. |
Q46457425 | Sequence variations in rgpA and rgpB of Porphyromonas gingivalis in periodontitis |
Q38248012 | Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases |
Q28085417 | The enduring importance of animal models in understanding periodontal disease |
Q27680674 | The lysine gingipain adhesin domains from Porphyromonas gingivalis interact with erythrocytes and albumin: Structures correlate to function |
Q37058550 | The use of rodent models to investigate host-bacteria interactions related to periodontal diseases |
Q53529199 | Three-dimensional quantification of alveolar bone loss in Porphyromonas gingivalis-infected mice using micro-computed tomography. |
Q37416211 | Toll gates to periodontal host modulation and vaccine therapy |
Q36899088 | Vaccination against periodontitis: the saga continues. |
Q42104265 | Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss |
Q34097025 | Vaccines against periodontitis: a forward-looking review |
Q52723333 | [Experimental research on Arginine-gingipain A gene vaccine from Porphyromonas gingivalis that prevents peri-implantitis in Beagle dogs]. |
Q53527510 | kgp, rgpA, and rgpB DNA vaccines induce antibody responses in experimental peri-implantitis. |
Q50242287 | rgpA DNA vaccine induces antibody response and prevents alveolar bone loss in experimental peri-implantitis |
Search more.